Lanoux-Nguyen Arthur S, Weis Lauren E, Zalman Currey M, Reilly Debra A, Figy Sean C, Florescu Marius C
From the Department of Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, NE.
College of Medicine, University of Nebraska Medical Center, Omaha, NE.
Plast Reconstr Surg Glob Open. 2024 Dec 18;12(12):e6371. doi: 10.1097/GOX.0000000000006371. eCollection 2024 Dec.
More than 65% of patients with end-stage renal disease (ESRD) use arteriovenous fistulas (AVFs) for hemodialysis. The increasing incidence of comorbid ESRD and obesity (body mass index, >35 kg/m) precludes patients from kidney transplantation, resulting in a need for long-term, durable AVF access. Compared with traditional superficialization techniques for overlying adiposity, liposuction is minimally invasive and well-tolerated, allowing for earlier fistula use with lower complications. We present the detailed surgical technique for superficialization of AVFs using liposuction.
Fourteen patients with well-matured but difficult-access fistulas due to adiposity were selected. Preoperative ultrasound mapped depth of fistulas. Tumescent liposuction was completed in a cross-hatched manner. Intraoperative ultrasound confirmed cannula positioning and measured fistula depth. A palpable thrill remained throughout superficialization. Cannulation began 4 weeks postoperatively.
Mean access depth preoperatively was 10.8 mm (8-15 mm), immediately postoperative was 7 mm (6-9 mm), and at 4 weeks was 5.3 mm (4-8 mm). The average usable access length was 12.7 cm (10-15 cm) after surgery. Thirteen fistulas were successfully accessed after liposuction superficialization. All patients were discharged home the same day. There were no postoperative infections or hemorrhage.
Early experience with liposuction for superficialization of deep hemodialysis access is promising. This innovative solution has the possibility to improve outcomes and quality of life for patients living with ESRD and obesity. Our experience shows that this is a safe and effective technique to increase patient eligibility, enable successful and early cannulation, and decrease recovery time.
超过65%的终末期肾病(ESRD)患者使用动静脉内瘘(AVF)进行血液透析。ESRD与肥胖(体重指数>35kg/m²)合并症的发病率不断上升,使患者无法进行肾移植,因此需要长期、耐用的AVF通路。与传统的用于处理皮下脂肪的浅表化技术相比,抽脂术微创且耐受性良好,可使内瘘更早投入使用且并发症更少。我们介绍了使用抽脂术使AVF浅表化的详细手术技术。
选择14例因肥胖导致内瘘成熟良好但难以穿刺的患者。术前超声确定内瘘深度。采用交叉网格方式完成肿胀抽脂术。术中超声确认套管位置并测量内瘘深度。在整个浅表化过程中始终可触及震颤。术后4周开始插管。
术前平均通路深度为10.8mm(8 - 15mm),术后即刻为7mm(6 - 9mm),4周时为5.3mm(4 - 8mm)。术后平均可用通路长度为12.7cm(10 - 15cm)。抽脂浅表化后13例内瘘成功实现穿刺。所有患者均于当日出院。无术后感染或出血情况。
抽脂术用于深部血液透析通路浅表化的早期经验很有前景。这种创新解决方案有可能改善ESRD和肥胖患者的治疗效果和生活质量。我们的经验表明,这是一种安全有效的技术,可增加患者的适应证,实现成功且早期的插管,并缩短恢复时间。